407 related articles for article (PubMed ID: 30678907)
1. Investigation of magnetic silica with thermoresponsive chitosan coating for drug controlled release and magnetic hyperthermia application.
Pon-On W; Tithito T; Maneeprakorn W; Phenrat T; Tang IM
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():23-30. PubMed ID: 30678907
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.
Montha W; Maneeprakorn W; Buatong N; Tang IM; Pon-On W
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():235-240. PubMed ID: 26652369
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermia evaluation and drug/protein-controlled release using alternating magnetic field stimuli-responsive Mn-Zn ferrite composite particles.
Montha W; Maneeprakorn W; Tang IM; Pon-On W
RSC Adv; 2020 Nov; 10(66):40206-40214. PubMed ID: 35520877
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
5. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy.
Jaiswal MK; Pradhan A; Banerjee R; Bahadur D
J Nanosci Nanotechnol; 2014 Jun; 14(6):4082-9. PubMed ID: 24738355
[TBL] [Abstract][Full Text] [Related]
6. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
Xu SS; Wu J; Jiang W
J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
[TBL] [Abstract][Full Text] [Related]
8. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive controlled release of mesoporous silica nanoparticles capped with Schiff base copolymer gatekeepers: Experiment and molecular dynamics simulation.
Peng S; Yuan X; Lin W; Cai C; Zhang L
Colloids Surf B Biointerfaces; 2019 Apr; 176():394-403. PubMed ID: 30660963
[TBL] [Abstract][Full Text] [Related]
11. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
13. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin hydrochloride - Loaded electrospun chitosan/cobalt ferrite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release.
Radmansouri M; Bahmani E; Sarikhani E; Rahmani K; Sharifianjazi F; Irani M
Int J Biol Macromol; 2018 Sep; 116():378-384. PubMed ID: 29723626
[TBL] [Abstract][Full Text] [Related]
15. P(EO-co-LLA) functionalized Fe3O4@mSiO2 nanocomposites for thermo/pH responsive drug controlled release and hyperthermia.
Guo W; Yang C; Lin H; Qu F
Dalton Trans; 2014 Dec; 43(48):18056-65. PubMed ID: 25353400
[TBL] [Abstract][Full Text] [Related]
16. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
[TBL] [Abstract][Full Text] [Related]
17. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin loaded dual pH- and thermo-responsive magnetic nanocarrier for combined magnetic hyperthermia and targeted controlled drug delivery applications.
Hervault A; Dunn AE; Lim M; Boyer C; Mott D; Maenosono S; Thanh NT
Nanoscale; 2016 Jun; 8(24):12152-61. PubMed ID: 26892588
[TBL] [Abstract][Full Text] [Related]
19. Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.
Efthimiadou EK; Tapeinos C; Chatzipavlidis A; Boukos N; Fragogeorgi E; Palamaris L; Loudos G; Kordas G
Int J Pharm; 2014 Jan; 461(1-2):54-63. PubMed ID: 24286923
[TBL] [Abstract][Full Text] [Related]
20. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]